U.S. and Europe Clinical Nutrition Market

The U.S. and Europe clinical nutrition market is estimated to be valued at USD 9,830.9 Mn in 2026 and is expected to reach USD 15,290.8 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033. Clinical nutrition involves the use of specialized nutritional products to support patients with inadequate dietary intake due to acute or chronic medical conditions. These include oral nutritional supplements, enteral nutrition and parenteral nutrition, all designed to improve nutritional status, enhance recovery, control disease progression and optimize overall clinical outcomes in a variety of healthcare settings. The U.S. and Europe clinical nutrition market is driven by the rising prevalence of chronic diseases, increasing disease-related malnutrition, and a growing geriatric population requiring specialized nutritional support. Demand is further supported by the increasing use of clinical nutrition in hospitals, long-term care facilities, home healthcare and rehabilitation centers, as well as increasing adoption of value-based healthcare approaches that recognize nutritional therapy as an effective way to improve patient outcomes while reducing healthcare costs. Market Dynamics The U.S. and Europe clinical nutrition market is primarily driven by the increasing prevalence of disease-related malnutrition, the rising geriatric population and the increasing burden of chronic diseases such as cancer, gastrointestinal disorders and metabolic conditions. In addition, the increasing focus on nutritional screening, advancements in disease-specific nutritional formulations and improving awareness of clinical nutrition as an essential part of patient care are further aiding the market growth across hospitals and long-term care settings. However, a number of constraints are present in the market, such as high cost of enteral and parenteral nutrition therapies, complex reimbursement policies, and stringent regulatory requirements governing clinical nutrition products. Nevertheless, increasing adoption of home-based clinical nutrition, expanding home enteral and parenteral nutrition services, and the development of personalized nutrition solutions based on precision medicine and microbiome research are expected to create significant growth opportunities over the forecast period. Key Features of the Study • This report provides in-depth analysis of the U.S. and Europe clinical nutrition market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the U.S. and Europe clinical nutrition market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Nestlé Health Science S.A., Danone S.A., Abbott Laboratories, Fresenius Kabi AG, B. Braun SE, Baxter International Inc., Reckitt Benckiser Group plc, Otsuka Pharmaceutical Co., Ltd., Ajinomoto Co., Inc., and Victus, Inc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The U.S. and Europe clinical nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. and Europe clinical nutrition market Market Segmentation • Route of Administration Insights (Revenue, USD Mn, 2021 - 2033) o Oral o Enteral o Parenteral • Application Insights (Revenue, USD Mn, 2021 - 2033) o Cancer o Metabolic Disorders o Gastrointestinal Disorders o Neurological Disorders o Others • Age Group Insights (Revenue, USD Mn, 2021 - 2033) o Adult o Pediatric o Geriatric • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • Key Players Insights o Nestlé Health Science S.A. o Danone S.A. o Abbott Laboratories o Fresenius Kabi AG o Braun SE o Baxter International Inc. o Reckitt Benckiser Group plc o Otsuka Pharmaceutical Co., Ltd. o Ajinomoto Co., Inc. o Victus, Inc.